ascopubs.org

Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: Final data from a ...

Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients (pts) with recurrent ovarian carcinoma. Background: Farletuzumab (MORAb-003) is a ...
Cure Today

Novel Antibody-Drug Conjugate to Be Tested in Lung, Gynecologic Cancers

A novel antibody-drug conjugate received an investigational new drug application for patients with gynecologic and lung cancers. The Food and Drug Administration (FDA) has cleared an investigational ...
Mena FN

Frat Health Launches Breakthrough Telehealth Service To Support Folate-Related Health Challenges

(MENAFN- EIN Presswire) EINPresswire/ -- Frat Health today announces the launch of its new telehealth platform dedicated to diagnosing and treating conditions linked to folate metabolism. The service ...
Business Wire

Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8006, an Antibody Drug Conjugate Targeting Folate Receptor α for the Treatment of Advanced Solid Tumors

GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating ...
Mena FN

Folate Receptor Alpha (Fra) Targeted Therapy Competitor Analysis Report 2025: Next Generation Cell Therapy Modalities And Radiopharmaceuticals Are Advancing In The Pipeline

(MENAFN- GlobeNewsWire - Nasdaq) Folate receptor alpha (FRα) presents strong market opportunities as a validated target, especially in ovarian and lung adenocarcinomas. Potential growth lies in ...